Alfonso Bencomo Álvarez, PhD, on Survival Outcomes for Hispanic Patients With Hematologic Cancers Living at the US/Mexico Border

Posted: Tuesday, July 28, 2020

Alfonso Bencomo Álvarez, PhD, of Texas Tech University Health Sciences Center, discusses the clinical implications of his findings that 10-year survival rates for Hispanic patients with ALL, AML, and CML were significantly lower for those who lived in El Paso than for those who lived elsewhere in Texas. He explains what this could mean for Hispanic patients in other regions of the United States, and how to possibly alter this disparity with policy decisions.